We then tested these drug combinations in the primary CLL cells, both in the native condition (Figure 7A) and in media supplemented with cytokines (CD40 ligand and interleukin-4) to mimic the microenvironment and maintain viability (Figure 7B). The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.